RGNX

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cardinal Health (CAH – Research Report) and RegenXBio (RGNX – Research Report). Cardinal Health (CAH) In a report issued on November 4, Steven Valiquette from Barclays maintained a Hold rating on Cardinal Health, with a price target of $77.00. The company's shares closed last Friday at $79.52, close to its 52-week high of $79.90. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-cardinal-health-cah-and-regenxbio-rgnx?utm_source=advfn.com&utm_medium=referral